This pentose phosphate pathway in humans with the reaction catalysed by<unk>  underlined. TALDO1 is either mutated by the deletion of residue Ser171 or a replacement of Arg192 by His or Cys, changing the formation of the protein. The deletion of Ser171 leads to inactivation and proteasome-mediated degradation of TALDO1. This shows the pentose phosphate pathway in humans with<unk>  catalysing the following reaction: D-glyceraldehyde 3-phosphate + D-sedoheptulose 7-phosphate D-fructose 6-phosphate + D-erythrose 4-phosphate
Transaldolase deficiency
Enolase deficiency
Aldolase A deficiency
Glutaminase deficiency
Pyruvate kinase deficiency
Ornithine aminotransferase deficiency
Malonyl-CoA decarboxylase deficiency
Hexokinase deficiency